Scott Gottlieb is stepping down as leader of the FDA — and many in health and medicine quickly turned to Twitter to express their displeasure.
Gottlieb, who has served as the commissioner of the Food and Drug Administration since May 2017, announced on Tuesday that he plans to leave his post in one month. During his tenure, the FDA broke annual records for generic drug approvals, cracked down on unproven stem cell treatments, and took new steps to curb youth e-cigarette use.
“This has been a wonderful journey and parting is very hard,” he said in a tweet of his own, adding that he was “immensely grateful for the opportunity to help lead this wonderful agency.”
About the Author Reprints
